GB2001971A - 1-(indol-4-yloxy)-3-amino-2- propanol derivatives - Google Patents

1-(indol-4-yloxy)-3-amino-2- propanol derivatives

Info

Publication number
GB2001971A
GB2001971A GB7830345A GB7830345A GB2001971A GB 2001971 A GB2001971 A GB 2001971A GB 7830345 A GB7830345 A GB 7830345A GB 7830345 A GB7830345 A GB 7830345A GB 2001971 A GB2001971 A GB 2001971A
Authority
GB
United Kingdom
Prior art keywords
hydrogen
cyano
alkoxy
halogen
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB7830345A
Other versions
GB2001971B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH907777A external-priority patent/CH632246A5/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB2001971A publication Critical patent/GB2001971A/en
Application granted granted Critical
Publication of GB2001971B publication Critical patent/GB2001971B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The compounds of formula I <IMAGE> wherein R is a group <IMAGE> wherein A is C2-5 alkylene, X is a bond, oxygen or sulfur, R3 is hydrogen, hydroxy, C1-4 alkoxy, halogen of atomic number of from 9 to 35, cyano, carbamoyl or a group NHCORd, wherein Rd is C1-4 alkyl, and R4 is hydrogen and, when R3 is C1-4 alkoxy, R4 additionally may be C1-4 alkoxy or, when R3 is halogen of atomic number of from 9 to 35, R4 additionally may be halogen of atomic number of from 9 to 35 either i) R1 is hydrogen or methyl and R2 is cyano, CONRaRb, COORc or CH2ORe, wherein Ra, Rb, Rc and Re independently are hydrogen or C1-4 alkyl, or ii) either R1 is methyl and R2 is Cl or Br or R1 is Cl or Br and R2 is hydrogen or methyl, with the provisos that a) X is separated from the nitrogen atom of the 3-amino-2-hydroxy-propoxy chain by at least 2 carbon atoms, b) when X is a bond, P3 is other than hydrogen and c) when R2 is cyano, R additionally may be C3-7 alkyl are useful as alpha - and beta -adrenoceptor blocking, anti-arrhythmic and anti- hypertensive agents and as inhibitors of metabolic effects of emotional stress.
GB7830345A 1977-07-21 1978-07-19 Organic compounds Expired GB2001971B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH907777A CH632246A5 (en) 1977-07-21 1977-07-21 Process for preparing novel 3-aminopropoxyindoles
CH907077 1977-07-21
CH907377 1977-07-21
CH906577 1977-07-21

Publications (2)

Publication Number Publication Date
GB2001971A true GB2001971A (en) 1979-02-14
GB2001971B GB2001971B (en) 1982-02-10

Family

ID=27429188

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7830345A Expired GB2001971B (en) 1977-07-21 1978-07-19 Organic compounds

Country Status (18)

Country Link
JP (1) JPS5422364A (en)
AU (1) AU523105B2 (en)
BE (1) BE869133A (en)
CA (1) CA1098909A (en)
DE (1) DE2830211A1 (en)
DK (1) DK312878A (en)
ES (1) ES471863A1 (en)
FI (1) FI782229A (en)
FR (1) FR2398058A1 (en)
GB (1) GB2001971B (en)
IE (1) IE47131B1 (en)
IL (1) IL55170A (en)
IT (1) IT1105092B (en)
NL (1) NL7807626A (en)
NZ (1) NZ187909A (en)
PT (1) PT68317A (en)
SE (1) SE435374B (en)
SU (1) SU843740A3 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2905877A1 (en) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh NEW AMINOPROPANOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE3068678D1 (en) * 1979-08-10 1984-08-30 Sandoz Ag 3-aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
DE3029980A1 (en) * 1980-08-08 1982-03-11 Boehringer Mannheim Gmbh, 6800 Mannheim INDOLDER DERIVATIVES AND METHOD FOR THEIR PRODUCTION
DE3030047A1 (en) * 1980-08-08 1982-03-11 Boehringer Mannheim Gmbh, 6800 Mannheim NEW AMINOPROPANOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE3131146A1 (en) * 1981-08-06 1983-02-24 Boehringer Mannheim Gmbh, 6800 Mannheim NEW HETEROARYLOXYPROPANOLAMINE, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US6022894A (en) 1996-04-09 2000-02-08 Nps Pharmaceuticals, Inc. Method of using calcilytic compounds
US6818660B2 (en) 1996-04-09 2004-11-16 Nps Pharmaceuticals, Inc. Calcilytic compounds
ATE215369T1 (en) * 1996-09-05 2002-04-15 Lilly Co Eli CARBAZOLE ANALOGUES AS SELECTIVE BETA3-ADRENERGIC AGONISTS
TW483881B (en) 1996-12-03 2002-04-21 Nps Pharma Inc Calcilytic compounds
US7202261B2 (en) 1996-12-03 2007-04-10 Nps Pharmaceuticals, Inc. Calcilytic compounds
WO2001036412A1 (en) * 1999-11-15 2001-05-25 Eli Lilly And Company Process for the preparation of aryloxy propanolamines
CN109310651A (en) * 2016-05-13 2019-02-05 小利兰·斯坦福大学董事会 Adrenergic receptor modulation compound and its application method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1547056A (en) * 1966-12-13 1968-11-22 Sandoz Sa Indole derivatives and their preparation
FR2019185A1 (en) * 1968-09-30 1970-06-26 Sandoz Sa 4-(2-hydroxy-3-amino-propoxy)-indole-2-carboxy- - lic acids and esters and 2-hydroxymethylindoles as beta
US3699123A (en) * 1970-03-24 1972-10-17 Sandoz Ltd 4-(3-amino-2-hydroxy-propoxy) indole derivatives
US4076829A (en) * 1974-11-16 1978-02-28 Boehringer Mannheim Gmbh Aminopropanol compounds and compositions for the treatment of cardiac and circulatory diseases
DE2508251C2 (en) * 1975-02-26 1983-12-29 Boehringer Mannheim Gmbh, 6800 Mannheim Derivatives of indole, processes for their preparation and medicaments containing them
DE2633839A1 (en) * 1975-08-07 1977-02-24 Sandoz Ag NEW 4-AMINOPROPOXYINDOLDE DERIVATIVES, THEIR PRODUCTION AND USE
DE2635209C2 (en) * 1975-08-15 1983-01-27 Sandoz-Patent-GmbH, 7850 Lörrach 4- (2-Benzoyloxy-3-tert-butylamino-propoxy) -2-methylindole, its (S) -enantiomer, their acid addition salts, processes for their preparation and medicaments containing these compounds

Also Published As

Publication number Publication date
IL55170A (en) 1982-07-30
DK312878A (en) 1979-01-22
SE7807753L (en) 1979-01-22
IT1105092B (en) 1985-10-28
IE781448L (en) 1979-01-21
AU3818278A (en) 1980-01-24
SE435374B (en) 1984-09-24
FR2398058B1 (en) 1982-08-06
JPS5422364A (en) 1979-02-20
IE47131B1 (en) 1983-12-28
FR2398058A1 (en) 1979-02-16
NZ187909A (en) 1981-04-24
IL55170A0 (en) 1978-09-29
CA1098909A (en) 1981-04-07
FI782229A (en) 1979-01-22
SU843740A3 (en) 1981-06-30
ES471863A1 (en) 1979-10-01
DE2830211A1 (en) 1979-02-01
BE869133A (en) 1979-01-19
PT68317A (en) 1978-08-01
NL7807626A (en) 1979-01-23
IT7850299A0 (en) 1978-07-14
AU523105B2 (en) 1982-07-15
GB2001971B (en) 1982-02-10

Similar Documents

Publication Publication Date Title
GB2001971A (en) 1-(indol-4-yloxy)-3-amino-2- propanol derivatives
GB2183647B (en)
SE8105240L (en) THEOPHYLLINE AND THEOBROMINE DERIVATIVES
ATE23716T1 (en) 5,6,7-TRINOR-4,8-INTER-M-PHENYLENE-PROSTAGLANDIN I2 DERIVATIVES.
PL348769A1 (en) 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
FI783456A (en) 1,9-DIHYDROXIOKTAHYDROFENANTRENER OCH MELLANPRODUKTER FOER DEM
DE3851123D1 (en) Liquid crystal compositions.
ES475635A1 (en) Imidazole derivatives
MX170732B (en) COMPOSITION OF SUCCINIMIDE DERIVATIVES AND THEIR USE
ES8301221A1 (en) Antihistaminic imidazoles
ES8101071A1 (en) 2-(Pyrid-2-yl)tetrahydrothiophene derivatives
ES466363A1 (en) N-9,10-dihydrolysergyl-m-aminobenzoic acid amide derivative
ES8301931A1 (en) Imidazoles.
CA1273946C (en) Anticonvulsant gamma-thiobutyrolactone derivatives
SE8504346L (en) N-ALKYL (S) -N- (O, O-DISUBSTITUTED THIOPHOSPHORIAL) -N &#39;, N&#39;-DISUBSTITUTED GLYCINAMIDES, SET TO PREPARE THESE AND ACARICID, INSECTICID AND FUNGICIDE, INCLUDING ITS COMPOSITION OF ITS COMPOSITION
ES459755A1 (en) Fungicidally active derivatives of carbamic acid oxime-esters of isonitrosocyanoacetic acid
EP0044266A3 (en) Substituted 3,5-diamino-1,2,4-oxadiazoles and 3,5-diamino-1,2,4-thiadiazoles, their preparation and use
MX9303989A (en) PIPERIDINIDIL PIRADIZINS PHENOXIALKYL HETEROCICLICAS AS ANTIVIRAL AGENTS.
ES467744A1 (en) Fungicide
GB2003866A (en) Thiourea derivatives
ES474746A1 (en) Derivatives of eburnamenine, their preparation and their therapeutical application.
IL67360A0 (en) Alpha-azolylglycols and their use as fungicides
ES8500909A1 (en) Benzimidazole derivatives
ES458818A1 (en) Phenyl- or cycloalkyl-benzo-oxacyclic compounds
ES8705426A1 (en) Piperazine derivative.

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee